The medical world is observing a remarkable shift in glucose treatment with the arrival of GLP-1 skin applications. These patches offer a seemingly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, minimizing the need for daily needle pricks. The approach administers the drug directly through the surface, ar